The Rising Cases Of Cancer, Immune Disorders Drives Flow Cytometry Market Growth
Flow Cytometry Market, by Technology (Cell Based, Bead Based), by Product Type (Analyzer, Sorter, Reagent & Consumables), by Application (Research, Clinical, Industrial), by End User (Hospitals, Clinical Testing Laboratories, Research Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 – 2030
The global Flow Cytometry Market is estimated to be valued at US$ 4,255.8 million in 2022 and is expected to exhibit a CAGR of 7.17 % over the forecast period, as highlighted in a new report published by Coherent Market Insights.
Market Overview
Flow cytometry is a laser-based method utilized to identify and study the chemical and physical features of cells or elements. It is very generally utilized to check bone marrow, peripheral plasma and other liquids in the body.
Competitive Landscape:
Key players included in the global flow cytometry for market are Sysmex Corporation, Agilent Technologies, Inc., Beckman Coulter, Inc., General Electric, BD, Miltenyi Biotec GmbH.,Laboratory Corporation of America Holdings., Cytek Biosciences, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Danaher, Enzo Life Sciences, Inc., Sartorius AG, BioLegend, Inc., and MilliporeSigma
Market Key Drivers:
The rising cases of cancer, immune disorders is expected to augment the growth of global Flow Cytometry Market. For instance, as per WCRF, around 18.1 million individuals died every year due to cancer globally.
The rising prevalence of infectious diseases such as AIDS is projected to propel the growth of global flow cytometry for market. For instance, as per the records published AIDS and TB lead to around 4.5 million deaths every year,
Covid-19 Impact Analysis:
The COVID-19 outbreak led to an expansion in the use of flow cytometry. The method provides an ensuring substitute for COVID-19 testing as it can handle the restraint of current antibody-based testing choices owing to its high accuracy and output capacity. Thus, the use of flow cytometry-based methods for COVID-19 diagnostics and disorder surveillance has led to the growth of the industry.
Key Takeaways:
The global Flow Cytometry Market is expected to exhibit a CAGR of 7.17 % during the forecast period owing to the rising expenditure in biopharma and technology. For instance, , in 2020, GlaxoSmithKline declared an expenditure of around US$ 250 million in Vir Biotechnology for developing its antibody drug innovation program for COVID-19.
Among regions, North America, Asia Pacific and Europe anticipated to witness robust growth in the global flow cytometry for market due to increasing prevalence of chronic diseases, rising investments and expenditure, frequent product launches and quick approvals. For instance, in September 2022, BD declared the introduction of a BD software solution particularly considered for flow cytometry workflow.

Comments
Post a Comment